We are interested in how cells and tissues adapt to changes in lipids in healthy and diseased states.
The Tarling Lab is focused on uncovering molecular mechanisms involved in maintaining cholesterol trafficking and homeostasis in immune cells in cardiopulmonary diseases.
The Vallim Lab is interested in identifying novel regulators of lipid metabolism in metabolic disease using a combination of global -omics and gene-targeted approaches.
Follow us on Twitter.
April 2023 – We welcome our newest graduate student, Rochelle Lai, to the lab!
March 2023 – Liz is awarded an AHA Established Investigator Award!
January 2023 – The ETV is celebrating a BIG anniversary (10 years) this year! Lots of fun things planned throughout the year
December 2022 – We ended the year in the best way with an NOA for a new MPI R01 to study the gut-liver axis in cardiovascular disease!
Take a look at our newest publication, in Circulation Research, where we find that the membrane-bound E3 ubiquitin ligase RNF130 regulates the abundance and availability of LDLR at the plasma membrane.
Check out our study, published in Nature, where we identify novel lipid biomarkers that predict the accumulation of pathological lipids in the livers of mice and humans.